Human papilloma virus test – European Clinical Trials Information Network https://clinicaltrials.eu Bridging Patients with Clinical Trials Fri, 12 Jun 2026 10:32:42 +0000 en-US hourly 1 https://wordpress.org/?v=7.0 https://clinicaltrials.eu/wp-content/uploads/2024/12/cropped-EU_icon-32x32.png Human papilloma virus test – European Clinical Trials Information Network https://clinicaltrials.eu 32 32 Study on the Effectiveness of 2LPAPI with Interferon Alfa in Clearing Genital HPV Infections in Patients https://clinicaltrials.eu/trial/study-on-the-effectiveness-of-2lpapi-with-interferon-alfa-in-clearing-genital-hpv-infections-in-patients/ Wed, 29 Apr 2026 14:29:34 +0000 https://clinicaltrials.eu/trial/study-on-the-effectiveness-of-2lpapi-with-interferon-alfa-in-clearing-genital-hpv-infections-in-patients/ This clinical trial is focused on studying the treatment of Human Papillomavirus (HPV) infection, specifically targeting high-risk types that can lead to genital infections. The treatment being tested is called 2LPAPI, which is a combination of several active substances including interferon alfa, ciclosporin A, interleukin-1, interleukin-2, ribonucleic acid, and specific nucleic acids known as SNA-HLA II and SNA-PAPI. These substances are designed to work together to help clear the virus from the body.

The purpose of this study is to compare the effectiveness of 2LPAPI with a placebo in clearing high-risk HPV infections over a period of 12 months. Participants in the study will receive either the 2LPAPI treatment or a placebo, and their progress will be monitored at regular intervals. The study is designed to be double-blind, meaning neither the participants nor the researchers will know who is receiving the actual treatment or the placebo, to ensure unbiased results.

Throughout the study, participants will have follow-up visits to check the status of the HPV infection and any changes in their health. The main goal is to see if the 2LPAPI treatment can effectively clear the HPV infection by the end of the study period. Additionally, the study will monitor the safety of the treatment by recording any side effects or adverse events that may occur. This research aims to provide valuable information on a potential new treatment option for those affected by high-risk HPV infections.

]]>